CART-19
- Generic Name
- CART-19
CD19-directed CAR-T Cell Therapy for R/R Acute Leukemia and Lymphoma
Phase 1
Recruiting
- Conditions
- Leukemia, Acute LymphoblasticLymphoma, Non-Hodgkin
- Interventions
- First Posted Date
- 2023-10-26
- Last Posted Date
- 2024-12-09
- Lead Sponsor
- University of Sao Paulo
- Target Recruit Count
- 81
- Registration Number
- NCT06101381
- Locations
- 🇧🇷
Hospital de ClÃnicas da UNICAMP, Campinas, SP, Brazil
🇧🇷Hospital SÃrio-Libanês, Sao Paulo, SP, Brazil
🇧🇷A Beneficência Portuguesa de São Paulo, Sao Paulo, SP, Brazil
Drug Development Updates
Stay informed with timely notifications on clinical trials, regulatory changes, and research advancements related to this medication.
© Copyright 2025. All Rights Reserved by MedPath